Company Overview
AKARI THERAPEUTICS PLC
AKTXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-17M
2025 FY
Shares Outstanding
67,328M
2025 FY
EPS
0USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1541157
Exchange
Nasdaq
Location
GB